Global Health 2050: The path to halving premature death by mid-century
Global Health 2050, the third report from the Lancet Commission on Investing in Health, provides a roadmap for achieving dramatic improvements in human welfare in high-, middle-, and low-income countries by mid-century with focused health investments. Published on October 14, 2024, the report shows that countries that choose to do so could achieve the goal of “50 by 50”—a 50% reduction in the probability of premature death, i.e., death before age 70 years, by 2050. The interventions that enable countries to achieve the goal of 50 by 50 should also reduce morbidity and disability at all ages.
Watch the pre-recorded at World Health Summit: Keynote – Global Health 2050: The Lancet Commission on Investing in Health 3.0
Watch the pre-recorded World Health Summit: Workshop 28 – "50 by 50" - What Will it Take to Achieve a 50% Reduction in Premature Deaths by 2050?
Global Health 2050 Launch
The Global Health 2050 report, the third report of the Lancet Commission on Investing in Health (CIH 3.0), will be launched on October 15, 2024, at a keynote event at the 2024 World Health Summit in Berlin, Germany. The launch will be chaired by Richard Horton, editor of The Lancet. It will feature four CIH 3.0 Commissioners, Angela Chang, Lia Tadesse, Dean Jamison, Seth Berkley, and two members of the CIH 3.0 Advisory Committee, Olive Shisana and Helen Clark. The report shows how focused health investments can achieve improvements in human welfare by 2050.
Angela Chang
Associate Professor, University of Southern Denmark
Lia Tadesse
Director, Harvard Ministerial Leadership Program
Dean Jamison
Professor Emeritus, Institute for Global Health Sciences, University of California, San Francisco; former Senior Economist and Chief, Health, Nutrition, and Population Division, The World Bank
Seth Berkley
Senior Adviser, Pandemic Center, Brown University School of Public Health; former CEO, Gavi, the Vaccine Alliance; former President.
Helen Clark
Board Chair, Partnership for Maternal, Newborn and Child Health
Olive Shisana
Special Advisor to the President of South Africa
In 2013, the Lancet published Global Health 2035, the first report of the Commission on Investing in Health (CIH 1.0), which provided a roadmap to achieving dramatic gains in global health by 2035. A second report (CIH 2.0) was published five years later to mark the 40 year anniversary of the influential Alma Ata Declaration on “health for all.” On October 15, 2024, we will publish a third report (CIH 3.0), called “Global Health 2050,” which identifies opportunities for investment in health in the post-COVID era that can succeed despite multiple headwinds, including rising geopolitical tensions and increasingly manifest climate change.
For CIH 3.0, we have convened an international group of 49 Commissioners. Our work is guided by expert advice from a high-level Advisory Committee chaired by John-Arne Røttingen, Chief Executive Officer of the Wellcome Trust.
The CIH is chaired by former U.S. Treasury Secretary Lawrence H. Summers, President Emeritus and the Charles W. Eliot University Professor at Harvard University, and co-chaired by Dean T. Jamison, Emeritus Professor in the Institute for Global Health Sciences at the University of California, San Francisco.
The Secretariat for CIH 3.0 is housed at the Center for Policy Impact in Global Health in the Duke Global Health Institute, Duke University, and the University of Bergen Centre for Ethics and Priority Setting in Health, Norway.
